Psychedelinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Oregon Psilocybin Services Act
Council: Voters must decide on psilocybin presence in town
Issue will appear on the November general election ballot whether to allow service centers to locate in Newberg
Right to Try
Bipartisan Senate Bill Would Give ‘Right to Try’ Protection to Psilocybin and MDMA
Sen. Cory Booker of New Jersey and Sen. Rand Paul of Kentucky have introduced bipartisan legislation to extend Right to Try protection to drugs that have completed a Phase 1 clinical trial, including psilocybin and MDMA.
DEA Sued Again Over Refusal To Allow Psilocybin Access For Patients Despite Federal Law
The Drug Enforcement Administration (DEA) is being sued—again—over its refusal to allow a doctor to treat terminally ill patients with psilocybin therapy pursuant to federal and state “Right to Try” (RTT) laws, which are aimed at expanding access to Schedule I investigational drugs that aren’t curre…
Decriminalization, Legalization & Other State Efforts
Groundbreaking Psychedelics Initiative Lands on Colorado’s November Ballot
Another group is still connecting signatures.
United States Federal Efforts
Biden Administration Plans for Legal Psychedelic Therapies Within Two Years
A letter from the Health and Human Services Department discloses the anticipated FDA approval of MDMA and psilocybin treatments.
DEA Cancels Proposed Ban Of Five Psychedelics, Giving Scientists More Time To Research Therapeutic Benefits
The Drug Enforcement Administration (DEA) has withdrawn a controversial proposal to ban five psychedelic compounds—a decision that’s being celebrated by advocates and researchers. Just weeks after posting a notice of a rare hearing that was scheduled in the face of broad pushback against the propose…
A Still-wary NIH Cozies up to Psychedelics Research
There are currently 57 NIH-funded projects about psychedelics (6 on psilocybin alone begun in the last three years).
Research, Science & Therapy
Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals
Working alongside Indigenous communities that pioneered the safe and effective use of psychedelics, and including them in governance and reward structures, is the ethical way forward for companies in this sphere.
Business
Psychedelics Company Numinus Acquires Novamind to Fuel US Expansion
Yet another company that uses psychedelics to treat mental illness is moving into the U.S. market. In June, Vancouver, Canada-based Numinus
World
The Mind Field
Inside the underground world of psychedelic therapy and the controversial charity pushing hard to bring the treatment into the mainstream.
Subscribe
Subscribe to Psychedelinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
